RxDoctor Payments Data

Matthew Cummock, DO

Neurological Surgery · Miami, FLNPI 1669869665

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Kyocera Medical Technologies, Inc. at 33.2% of the total. 2025 is the largest year on record at $25,456, 2.4 times the $10,542 reported in 2022.

$54,907in general payments, 2019–2025

Across 236 payments — averaging $232.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kyocera Medical Technologies, Inc.$18K
  • Globus Medical$15K
  • Alphatec Spine, Inc$8K
  • Stryker$4K
  • Spineology Inc.$3K
  • Medtronic$2K
  • plus $5K from 22 others

What the payments were for

  • Consulting fees$19,80036%
  • Travel & lodging$16,17229%
  • Food & beverage$18,77334%
  • Entertainment$1620%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,907 in reported general payments places this provider in the 80th percentile of 556 neurological surgery providers in Florida.

See all neurological surgery providers in Florida →

Medicare billing

Part B allowed, 2024
$68,163
Medicare patients
60
Services billed
171

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib40$1,506
Cyclobenzaprine Hcl66$491
Gabapentin47$444
Tramadol Hcl13$53

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Miami

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →